Related Experiment Video
Updated: Oct 14, 2025

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
Association of TIMP-2 Rs8179090 Genotypes With Lung Cancer Risk in Taiwan
Wei-Chih Liao1,2, Chien-Wen Huang3, Te-Chun Hsia1,4
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, R.O.C.
Background/Aim:
The tissue inhibitor of metalloproteinase-2 (TIMP-2) is a critical inhibitor of matrix metalloproteinases (MMPs). Along with MMPs, TIMP-2 regulates the breakdown and remodeling of the extracellular matrix (ECM) and basement membranes. This study investigated the role of genotypes of the TIMP-2 -418G/C (rs8179090) single nucleotide polymorphism on lung risk.
Materials And Methods:
A total of 358 lung cancer patients and 716 healthy subjects were recruited in this study. Genotypes were identified via the polymerase chain reaction-restriction fragment length polymorphism methodology.
Results:
The distribution of alleles and genotype frequencies of TIMP-2 -418G/C genotypes between the two groups were compared and no statistically significant difference (p>0.05) was found. The heterozygous and homozygous variant genotypes showed no differential distribution between the control and case groups (p>0.05).
Conclusion:
TIMP-2 -418G/C variants might not be associated with lung cancer susceptibility and could not serve as predictors.
Insights
The tissue inhibitor of metalloproteinase-2 (TIMP-2) -418G/C gene variant does not appear to influence lung cancer risk. This genetic variation is unlikely to be a reliable predictor for developing lung cancer.
Area of Science:
- Genetics and Genomics
- Cancer Biology
- Molecular Medicine
Background:
- The tissue inhibitor of metalloproteinase-2 (TIMP-2) is a key regulator of extracellular matrix (ECM) degradation and remodeling.
- TIMP-2, alongside matrix metalloproteinases (MMPs), plays a crucial role in maintaining tissue homeostasis.
- Dysregulation of ECM remodeling is implicated in various diseases, including cancer.
Purpose of the Study:
- To investigate the association between the TIMP-2 -418G/C single nucleotide polymorphism (SNP) and the risk of developing lung cancer.
- To determine if specific genotypes of the TIMP-2 -418G/C polymorphism are linked to lung cancer susceptibility.
Main Methods:
- A case-control study was conducted with 358 lung cancer patients and 716 healthy controls.
- Genotyping for the TIMP-2 -418G/C (rs8179090) polymorphism was performed using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.
Main Results:
- No statistically significant differences were observed in the distribution of TIMP-2 -418G/C allele and genotype frequencies between lung cancer patients and healthy controls (p>0.05).
- The frequencies of heterozygous and homozygous variant genotypes of TIMP-2 -418G/C did not differ significantly between the case and control groups (p>0.05).
Conclusions:
- The studied TIMP-2 -418G/C genetic variants are unlikely to be associated with lung cancer susceptibility.
- These specific TIMP-2 gene variants may not serve as effective predictive biomarkers for lung cancer risk.
More Related Videos
11:20Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
Published on: March 21, 2018
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons